Your browser doesn't support javascript.
loading
The Prognostic Significance of Low-Frequency Somatic Mutations in Metastatic Cutaneous Melanoma.
Zhao, Xiaobei; Little, Paul; Hoyle, Alan P; Pegna, Guillaume J; Hayward, Michele C; Ivanova, Anastasia; Parker, Joel S; Marron, David L; Soloway, Matthew G; Jo, Heejoon; Salazar, Ashley H; Papakonstantinou, Michael P; Bouchard, Deeanna M; Jefferys, Stuart R; Hoadley, Katherine A; Ollila, David W; Frank, Jill S; Thomas, Nancy E; Googe, Paul B; Ezzell, Ashley J; Collichio, Frances A; Lee, Carrie B; Earp, H Shelton; Sharpless, Norman E; Hugo, Willy; Wilmott, James S; Quek, Camelia; Waddell, Nicola; Johansson, Peter A; Thompson, John F; Hayward, Nicholas K; Mann, Graham J; Lo, Roger S; Johnson, Douglas B; Scolyer, Richard A; Hayes, D Neil; Moschos, Stergios J.
Afiliación
  • Zhao X; Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.
  • Little P; Department of Biostatistics, Gillings School of Public Health, The University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.
  • Hoyle AP; Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.
  • Pegna GJ; Division of Hematology/Oncology, Department of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.
  • Hayward MC; Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.
  • Ivanova A; Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.
  • Parker JS; Department of Biostatistics, Gillings School of Public Health, The University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.
  • Marron DL; Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.
  • Soloway MG; Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.
  • Jo H; Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.
  • Salazar AH; Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.
  • Papakonstantinou MP; Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.
  • Bouchard DM; Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.
  • Jefferys SR; Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.
  • Hoadley KA; Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.
  • Ollila DW; Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.
  • Frank JS; Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.
  • Thomas NE; Division of Surgical Oncology, Department of Surgery, The University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.
  • Googe PB; Melanoma Program, The University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.
  • Ezzell AJ; Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.
  • Collichio FA; Melanoma Program, The University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.
  • Lee CB; Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.
  • Earp HS; Melanoma Program, The University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.
  • Sharpless NE; Department of Dermatology, The University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.
  • Hugo W; Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.
  • Wilmott JS; Melanoma Program, The University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.
  • Quek C; Department of Dermatology, The University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.
  • Waddell N; Department of Cell Biology & Physiology, Histology Research Core Facility, The University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.
  • Johansson PA; Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.
  • Thompson JF; Division of Hematology/Oncology, Department of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.
  • Hayward NK; Melanoma Program, The University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.
  • Mann GJ; Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.
  • Lo RS; Division of Hematology/Oncology, Department of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.
  • Johnson DB; Melanoma Program, The University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.
  • Scolyer RA; Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.
  • Hayes DN; Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.
  • Moschos SJ; Division of Dermatology, Department of Medicine, Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA, United States.
Front Oncol ; 8: 584, 2018.
Article en En | MEDLINE | ID: mdl-30662871

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Front Oncol Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Front Oncol Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos